Wang M - Search Results

1

Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer.

Jin J, Xiang W, Wu S, Wang M, Xiao M, Deng A. Jin J, et al. Among authors: wang m. Biochem Biophys Res Commun. 2019 Mar 19;510(4):580-586. doi: 10.1016/j.bbrc.2019.01.117. Epub 2019 Feb 7. Biochem Biophys Res Commun. 2019. PMID: 30739792

2

miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer.

Guo J, Liu X, Wang M. Guo J, et al. Among authors: wang m. Biochem Biophys Res Commun. 2015 Sep 4;464(4):1302-1308. doi: 10.1016/j.bbrc.2015.07.127. Epub 2015 Jul 29. Biochem Biophys Res Commun. 2015. PMID: 26231797

3

Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.

Wang M, Liu X, Guo J, Weng X, Jiang G, Wang Z, He L. Wang M, et al. Among authors: wang z. Biochem Biophys Res Commun. 2015 Nov 13;467(2):310-5. doi: 10.1016/j.bbrc.2015.09.164. Epub 2015 Oct 3. Biochem Biophys Res Commun. 2015. PMID: 26435505

4

DOK1/PPARgamma pathway mediates anti-tumor ability of all-trans retinoic acid in breast cancer MCF-7 cells.

Ding X, Wang W, Wang M, Wu J, Yao F. Ding X, et al. Among authors: wang w, wang m. Biochem Biophys Res Commun. 2017 May 27;487(2):189-193. doi: 10.1016/j.bbrc.2017.04.018. Epub 2017 Apr 8. Biochem Biophys Res Commun. 2017. PMID: 28396148

5

LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.

Wang R, Huang Z, Qian C, Wang M, Zheng Y, Jiang R, Yu C. Wang R, et al. Among authors: wang m. Biochem Biophys Res Commun. 2020 Jun 11;526(4):1005-1012. doi: 10.1016/j.bbrc.2020.01.170. Epub 2020 Apr 16. Biochem Biophys Res Commun. 2020. PMID: 32307083

6

The circACC1/miR-29c-3p/FOXP1 network plays a key role in gastric cancer by regulating cell proliferation.

Chen X, Liu C, Ji L, Wang N, Liu Y, Wang M, Ruan L. Chen X, et al. Among authors: wang n, wang m. Biochem Biophys Res Commun. 2021 Jun 11;557:221-227. doi: 10.1016/j.bbrc.2021.04.028. Epub 2021 Apr 19. Biochem Biophys Res Commun. 2021. PMID: 33887587

7

MiR-142-3p functions as an oncogene in prostate cancer by targeting FOXO1.

Tan YF, Chen ZY, Wang L, Wang M, Liu XH. Tan YF, et al. Among authors: wang l, wang m. J Cancer. 2020 Jan 14;11(6):1614-1624. doi: 10.7150/jca.41888. eCollection 2020. J Cancer. 2020. PMID: 32047567 Free PMC article.

8

Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.

Tan Y, Wang L, Du Y, Liu X, Chen Z, Weng X, Guo J, Chen H, Wang M, Wang X. Tan Y, et al. Among authors: wang x, wang l, wang m. Int J Oncol. 2018 Dec;53(6):2503-2517. doi: 10.3892/ijo.2018.4577. Epub 2018 Sep 27. Int J Oncol. 2018. PMID: 30272279 Free PMC article.

9

EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway.

Chen Z, Du Y, Liu X, Chen H, Weng X, Guo J, Wang M, Wang X, Wang L. Chen Z, et al. Among authors: wang x, wang l, wang m. Oncol Lett. 2019 Jul;18(1):907-915. doi: 10.3892/ol.2019.10359. Epub 2019 May 14. Oncol Lett. 2019. PMID: 31289569 Free PMC article.

10

Effects of apigenin pretreatment against renal ischemia/reperfusion injury via activation of the JAK2/STAT3 pathway.

Liu Y, Wang L, Du Y, Chen Z, Guo J, Weng X, Wang X, Wang M, Chen D, Liu X. Liu Y, et al. Among authors: wang x, wang l, wang m. Biomed Pharmacother. 2017 Nov;95:1799-1808. doi: 10.1016/j.biopha.2017.09.091. Epub 2017 Oct 6. Biomed Pharmacother. 2017. PMID: 28962085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68,471 results

Search Page

Filters